ArticleViruses2024
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants?
Anna Gidari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleViruses2024
Anna Gidari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.